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perfusion machine RM3 and IGL-1 solution in a
preclinical kidney transplantation model
Raphael Thuillier1,2,3,4†, Ricardo Codas3,4†, Etienne Marchand5, Hubert Lathelize6, Olivier Page6, Alexandre Valagier7,
Lionel Badet1,3,7,8,9 and Thierry Hauet1,2,3,10,11*Abstract
Background: Machine perfusion (MP) of kidney graft provides benefits against preservation injury, however
decreased graft quality requires optimization of the method. We examined the chronic benefits of MP on kidney
grafts and the potential improvements provided by IGL-1 solution.
Method: We used an established autotransplantation pig kidney model to study the effects of MP against the
deleterious effects of warm ischemia (WI: 60 minutes) followed by 22 hours of cold ischemia in MP or static cold
storage (CS) followed by autotransplantation. MPS and IGL-1 solutions were compared.
Results: Animal survival was higher in MPS-MP and both IGL groups. Creatinine measurement did not discriminate
between the groups, however MPS-MP and both IGL groups showed decreased proteinuria. Chronic fibrosis level
was equivalent between the groups. RTqPCR and immunohistofluorescent evaluation showed that MP and IGL-1
provided some protection against epithelial to mesenchymal transition and chronic lesions. IGL-1 was protective
with both MP and CS, particularly against chronic inflammation, with only small differences between the groups.
Conclusion: IGL-1 used in either machine or static preservation offers similar levels of protection than standard MP.
The compatibility of IGL-1 with both machine perfusion and static storage could represent an advantage for clinical
teams when choosing the correct solution to use for multi-organ collection. The path towards improving machine
perfusion, and organ quality, may involve the optimization of the solution and the correct use of colloids.Background
Nowadays, kidney transplantation is the best treatment
for patients with end-stage renal disease, with long-term
benefits on patient survival and quality of life [1]. How-
ever, this therapy is now a victim of its success, with an
increasing shortage of organs: in 2010 in the USA,
15,429 kidney transplants were performed for 87,903
patients on the waiting list (OPTN, 2010). This leads to
donor demographic changes as transplantation centers
now accept more extended criteria donors (ECD). These
donors are defined as presenting co-morbidity factors
such as age, death from cardiovascular causes,* Correspondence: t.hauet@chu-poitiers.fr
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reproduction in any medium, provided the orcardiovascular risk factors or a reduction in glomerular
filtration [2]. These conditions increase the sensitivity of
the organ to preservation conditions [3]. Furthermore,
there is renewed interest in deceased after cardiac death
donors (DCD) [4], also displaying an increased rate of
delayed graft function (DGF) and a higher incidence
of primary non function [5]. The increased proportion of
these types of donors has lead to re-thinking of proper
organ preservation methods as in order to fully use these
sources an important effort must be made to improve
organ quality through better preservation.
Machine perfusion (MP) is based on a controlled cir-
culation of a solution within the organ for the duration
of the preservation. MP improves the quality of kidneys
in the clinic [6] and is particularly efficient in decreasing
both primary non function and DGF in ECD [7] as well
as DGF in DCD transplantation [8]. These benefits are
also fuelling debate about the cost effectiveness of thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[9]. However, despite its significant efficiency in reducing
DGF and increasing three year survival [10], a high inci-
dence of failure remains, highlighting the need for
improvements to be made on this method in order to
bring it to its full potential.
In a previous study, we measured the benefits of MP
versus static cold storage (CS) using the Waters RM3
system in a preclinical model of DCD kidney transplant-
ation in pigs [11,12]. In the same study, we analyzed the
possible benefits of using the IGL1 (Institute George
Lopez 1) solution in the system instead of the recom-
mended MPS (Machine Perfusion Solution). Indeed
IGL-1 is a fourth generation preservation solution con-
taining polyethylene glycols (PEG), which offer several
advantages in preservation solutions: they are non toxic,
neutral, water soluble, and their high affinity for water
molecules along their chain creates layers of ‘structured
water’ when they are adsorbed to the cell surface, offer-
ing an ‘exclusion volume’ preventing cells and proteins
fixations, as in the case of the immunological synapse
[13], offering the possibility of ‘immunocamouflage’ [14].
Protection from the immune system is also provided by
the effect of PEG binding on cell surface potential gradi-
ent, affecting charge-charge and non-covalent binding/
adhesion involved in antigen–antibody recognition. We
determined in this short term study that there was a
clear protection from MP when compared to CS, inde-
pendently of the solution, and that there was a slight ad-
vantage from using MPS over IGL1 in MP, as kidneys
preserved with the later showed some increase in the
level of tissue injury recorded on an anatomopathologi-
cal scale.
Herein we propose the results of the aforementioned
study with a longer follow up (3 months), with the aim
to provide more discriminating data between the groups.
Indeed, 3 months after transplant is the time of choice
for protocol biopsies in patients, allowing for estimation
of the development of chronic lesions such as interstitial
fibrosis and tubular atrophy. In our pig model, we previ-
ously showed that 3 months was also a valuable time to
evaluate the chronic consequences of preservation, par-
ticularly regarding chronic injuries.
We performed these experiments in a pig model of
kidney transplantation, reproducing conditions of DCD,
which present the advantage of using the same machines
as the clinic [11]. In this setting, we subject the kidney
to 60 min of warm ischemia prior to 22 hours of
hypothermic pulsatile perfusion in RM3, a model reflect-
ive of the uncontrolled DCD (Maastricht classes I and
II). It provides pre clinically relevant information com-
paring the effects of MP with the commonly used static
cold storage solutions. The model allows the direct as-
sessment of IRI and renal and tubular cell functionwithout the complication of immunogenic factors or re-
cipient characteristic. In addition, porcine kidneys are of
similar size and weight than adult human kidney and are
one of the two biomedical animals (with large primates)
presenting a multilobular and multipapillary kidney and
an elaborate system of interlobular and segmental arter-
ies to supply the numerous kidney lobes, it is therefore
well adapted for the modeling of kidney transplantation
[15]. The present study uses an isograft model, devoid of
the influence of both brain death and immunosuppres-
sants. This route was chosen because we felt that immu-
nosuppressors, with their own set of deleterious side
effects, would bias our results. Furthermore, machine
perfusion has been developed to optimize graft preserva-
tion, hence address ischemia reperfusion injury, leading
us to run this first series of tests on a non-brain dead ani-
mal. It is also important to note that our model is
designed to follow the setting of classes I and II of the
Maastricht criteria, but does not fit it exactly. Indeed, this
criteria includes no more than 30 min arrest before start-
ing the CPR procedure, which is then continued during
the transport to the hospital (generally with a machine);
then as failure to resuscitate is pronounced there is a
5 min no touch period. All these steps should not exceed
150 min before femoral vessels canulation. The donor
is then either cold perfused or an extracorporeal circuit
is put in place, giving enough time to secure consent
from the family and collect the organs, which are then
machine perfused. Our current model does not include
all these steps, however we trust that 60 min WI repro-
duces as closely as possible the conditions of DCD.
Lastly, although our model does not include brain death
and thus cannot be used to draw direct conclusions in
regards to ECD organ transplantation, the high degree
of injury encountered by the organ suggest that any
intervention proven beneficial in this model is likely to
improve ECD organ quality and thus would warrant a
dedicated investigation with an appropriate model.
Methods
Animal model and surgical procedure
Left kidneys from 28 large white pigs aged 4 weeks and
weighting 40 ± 4 kg were collected after vascular clamp-
ing of the renal vessels for 60 min (warm ischemia, WI)
preceded by administration of 150 U/kg heparin 10 min
before clamping the left/or right renal artery. Then the
organ was removed and immediately cold-flushed with
500-600 mL of preservation solution at a constant pres-
sure of 75 mmHg (Belzer MPS or IGL-1 placed at 1 m
of height). There was no difference in time or volume of
flush out between the groups. Kidneys were preserved
during 22 hours at 4°C. Four groups were studied: MPS-
CS: static incubation with Belzer MPS (n = 7); MPS-
MP: renal perfusion with Belzer MPS using the RM3
Table 1 Kidney function recovery after reperfusion
Groups Serum Creatinine (μmol/L)
D-1 D5 D7 D14
MPS CS 89.3 ± 4.6 1475.1 ± 72.4 1531.6 ± 407.4 1254.4 ± 655.7
MPS MP 92.1 ± 4.8 1225.7 ± 184.7 1225.7 ± 184.7 * 179.4 ± 20.2 *
IGL CS 81.0 ± 4.4 1135.3 ± 161.8 1135.3 ± 161.8 * 168.4 ± 19.5 *
IGL MP 82.0 ± 5.8 1389.3 ± 158.3 1389.3 ± 158.3 * 213.6 ± 19.1 *
Values are mean ± SEM. Statistics: *: p < 0.05 versus MPS-CS; ‡: p < 0.05 to IGL
CS; ¶: p < 0.05 to MPS MP.
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CS: with IGL-1 solution in static conservation (n = 7);
IGL-MP: renal perfusion with IGL-1 (n = 7). Afterwards,
the kidney was re-implanted and the contralateral was
removed. Heparin (5000U) was injected prior to clamping
pre-anastomosis. The heterotopic autotransplantation of
the left kidney using end-to-side aorta and vena cava anas-
tomosis was performed via the mid-line incision, as previ-
ously reported [16]. In all cases, re-warming ischemia
during implantation until anastomosis was 30 ± 5 min. A
control group of 3 animals was performed to assess the
normal values of creatinine in pigs with a single nephrec-
tomy. All animal experiments were conducted according
to the guidelines of the French Ministry of Agriculture for
the use and care of laboratories animals.
Renal function evaluation
Pigs were placed in metabolic cages for 24-h urine col-
lections. Blood and urinary samples were collected.
Plasma creatinine and proteinuria were measured with a
Modular bioanalyser (Roche Diagnostics, France).
Morphological study
Corticomedullar kidney samples were collected at
3 months. A standard procedure was used to estimate
the level of tubulointerstitial fibrosis using Picro-Sirius
staining [17] on 5–10 fields (100X). For immunohisto-
fluoresence, anti-Vimentin antibody (Cell Marque,
Rocklin, CA, USA) was used with secondary antibody
coupled with Cy3 (Invitrogen). Quantitative evaluation
was performed in silico on 35 high powered fields (5 per
animal, 200X).
Real Time quantitative PCR (RTqPCR)
We used Trizol for RNA extraction (Fisher Scientific,
France). Genomic DNA was removed using DNA-free
kit (Applied Biosystems, USA) and first-strand reverse
transcription (Applied) was performed. Real Time PCR
assays were performed on an ABI Prism 7300 (Applied).
Porcine primers (Additional file 1: Table S1) were
designed using OligoPerfect™ (Invitrogen, USA). Expres-
sion level was obtained with the 2(−ΔΔCt) Method. Con-
trols are age-matched kidneys which have not beet
subjected to ischemia reperfusion.
Statistical methods
Results are shown as mean±SEM. For the statistical ana-
lysis among groups, we used NCSS software (NCSS
LLC, USA) and one-way ANOVA analysis. In case the
ANOVA revealed statistical differences, Tukey-Kramer
post-hoc test for multiple comparisons in case of nor-
mality (Skewness, Kurtosis and Omnibus tests) and
equality of variance (Modified-Levene Equal-VarianceTest) and Kruskal-Wallis Multiple-Comparison Z-Value
Test (Dunn's Test) in case these parameters were not
met. For the multivariate analysis of variance, the Wilks'
Lambda, Hotelling-Lawley Trace, Pillai's Trace and Roy's
Largest Root tests were used to evaluate the hypothesis
that the solution and/or the machine had no effect on
the variable, and in case the hypothesis was rejected the
analysis of variance for each factor and for their inter-
action was conducted. Statistical significance was
accepted for P < .05.
Results
Early function recovery
Compared to MPS-CS, the decrease in serum creatinine
levels post-transplantation was faster in the MPS-MP,
IGL-CS and IGL-MP groups (Table 1), particularly evi-
denced by the levels reached at day 14. There was no
statistically significant difference between these three
groups.
3month survival and function
At the end of the follow up, only 57% of animals in the
MPS-CS group survived while all animals of the other
groups were able to reach the end of the follow up
(Figure 1A, P < .05). Animal loss during follow up was
due to renal failure, 3 cases of animal loss due to surgi-
cal errors (1 anastomosis failure, 2 bowel misplacement)
were excluded from the analysis. No sign of vascular
thrombosis was observed. Renal function of surviving
animals showed no differences between the groups in
terms of serum creatinine (Figure 1, B). There was a
higher level of proteinuria in the MPS-CS group com-
pared to the other three groups (Figure 1, C, P < .05).
Chronic fibrosis development
Analysis of interstitial fibrosis intensity revealed similar
levels in all groups (around 15%), typical for fibrosis in
its earlier stages (Figure 1 D-H).
Activation of injury mechanisms
We performed RTqPCR on markers of chronic kidney
lesion pathways and determined that grafts from all
groups demonstrated heightened levels of stress, as
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Figure 1 Functional and histological phenotype at 3 months. A-B: Animal Survival and graft function. A: Kaplan-Meier representation of
animal survival. B: Serum creatinine and C: proteinuria. D-H: Interstitial Fibrosis and Tubular Atrophy at 3 months. D: Quantification of staining in
each group E-H: Representative red Sirius staining for all 4 conditions. Shown are mean ± SEM. Statistics: *: P < .05 versus MPS-CS; ‡: P < .05 to IGL
CS; ¶: P < .05 to MPS MP.
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Figure 2 RTqPCR of chronic stress and fibrosis factors at 3 month. Quantification of gene expression was computed as stated in Methods.
Shown are mean ± SEM. Statistics: *: P < .05 versus MPS-CS; ‡: P < .05 to IGL CS; ¶: P < .05 to MPS MP.
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(Figure 2, A). Oxidative stress was also present, with
equivalent expression of NADPH oxidase subunit Nox 2
in all groups, while p47phox subunit showed higher ex-
pression in the MPS-CS group compared to the other
three groups (Figure 2, B).Activation of fibrosis development mechanisms
We measure the expression of pro-fibrosis markers by
RTqPCR (Figure 2 C) and determined a similar level of
overexpression for PAI1 in all groups. Thrombospondin
1 (Tsp1) was also overexpressed in all groups although
slightly reduced in IGL-MP. Connective tissue growth
factor (CTFG) overexpression was detected in all group,
with some reduction in MPS-MP kidneys. Interestingly,
expression of transforming growth factor β (TGFβ) was
only detected in MPS-CS grafts.
Investigating mediators of epithelial to mesenchymal
transition (Figure 2, D), we measured a trend towards
overexpression of Vimentin in MPS-CS kidneyscompared to the other groups, seemingly confirmed by
S100A4 measurements.
Epithelial to mesenchymal transition (EMT)
We performed immunohistofluorescent staining for
Vimentin and determined that in concordance with
RTqPCR data, staining intensity was high in the MPS-
CS Group (Figure 3) while it remained low in all three
other groups (P < .05).
Chronic inflammation markers
We further defined the inflammatory situation by
RTqPCR. Expression of TNFα was high in MPS-CS
group while it appeared lowered in both MPS-MP and
IGL-CS groups. IGL-MP group showed highly decreased
expression for this marker, suggesting a likely negative
regulation of inflammation at the time of analysis
(Figure 4, A). This trend was also observed in other
innate immunity markers, as MCP1 appears overex-
pressed in the MPS-CS group compared to the other two
(Figure 4, B). TLR4 and TLR2 expression analysis
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sion in IGL-MP compared to MPS-CS (Figure 4, B). IGL
groups also showed significantly lowered expression of
adaptative markers IL10 and IL1Rn compared to MPS-
CS (Figure 4, C), and diminished expression of endothe-
lial activation marker P selectin (Figure 4, D).
Multivariate analysis of variance
In order to measure the influence of the preservation so-
lution (MPS or IGL1) and the mode of preservation (MP
or CS) on organ quality, both their individual contribu-
tion and their interaction, we performed a multivariate
analysis of variance on proteinuria and vimentin staining
at 3 months (Table 2).
The results show that each factor plays an important
individual role for these parameters, as demonstrated by
the high F ratio and low p value. Interestingly, the influ-
ence of the interaction between solution and mode of
preservation was also high, indicating that theimprovement brought by the combination of factors is
more than the simple addition of their individual
contribution.
Discussion
In the present study, we confirmed previous findings
demonstrating the benefits of MP on chronic kidney graft
outcome [11]. Considering the importance of the solu-
tion bias when measuring the impact of machine preser-
vation [18] and the fact that we previously demonstrated
the superiority of MP over CS, all other parameters
being equal [12,19], we did not include in the present
study a CS group using standard static preservation so-
lution (for instance University of Wisconsin) as we felt a
repetition of these experiments would represent an un-
ethical use of animals, in addition, an non-randomized
prospective multi-center study showed that in clinical
practice IGL-1 solution has the same effectiveness as
UW solution in cold storage [20]. However, in previous
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of Wisconsin preservation, we found serum creatinine
levels of approximately 400 μmol/L at 3 months [21],
which when compared to the data of the present sug-
gests superiority of MP versus CS when these modesTable 2 Multivariate analysis of variance results
Factor
Sum of Squares Mean Squ
A: Solution 6,801158 6,80115
B: Mode of Preservation 9,683869 9,68386
AB: Interaction 7,065302 7,06530
S: Residual variance 9,16562 0,654687
Factor Sum of Squares Mean Squ
A: Solution 0,844812 0,84481
B: Mode of Preservation 0,788403 0,78840
AB: Interaction 1,239591 1,23959
S: Residual variance 0,3650857 1,738503Eare used in clinic-like conditions. Nevertheless, use of
MPS for both CS and MP permitted the measurement
of the benefits of the RM3 without interference from
solution components, and indeed when using MPS,
recommended solution for the RM3 machine, we showVimentin Staining at 3 months
are F-Ratio Probability level Power
8 10,39 0,006132 0,849834
9 14,79 0,001782 0,946426
2 10,79 0,005421 0,862812
2
Protéinuria at 3 months
are F-Ratio Probability level Power
2 48,59 0,000001 0,999998
3 45,35 0,000001 0,999996
1 71,30 0,000000 1,000000
-02
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function parameters such as proteinuria compared to
static storage. However, other typical parameters such
as serum creatinine and fibrosis were not changed by
the machine. In depth analysis of the phenotypes within
the kidney graft by RTqPCR showed decreased levels
in the expression of markers typical of chronic lesion
such as Notch 4, which has been shown to inhibit angio-
genesis [22], thus likely impeding the proper reparation
mechanisms within the graft. We also detected lower
p47phox expression in MPS-MP group, a subunit of
NADPH oxidase. NADPH oxidase is a protein complex
located in the plasma membrane as well as in the mem-
brane of phagosome, which variation in expression have
been linked to the level of oxidative stress in the tissue
and to chronic injury [23]. Thus, MP appears beneficial
in regards to chronic stress on the parenchyma.
Another important mechanism of chronic kidney graft
lesion is epithelial to mesenchymal transition, during
which epithelial cells differentiate and alter their pheno-
type towards that of a mesenchymal cell, thus going
from a polarized, anchored and non dividing cell to an
unpolarized, mobile and fast proliferating cell. This re-
generative process is believed to be deregulated and pro-
mote fibrosis in the context of chronic graft rejection
[24]. We investigated this phenomenon by first using
RTqPCR to observe expression of Vimentin, typical mar-
ker of EMT, and CTGF, an important downstream ef-
fector of TGF-β involved in fibrosis [25] and EMT [26].
In our study, MPS-MP grafts had decreased expression
of these markers compared to MPS-CS graft, a result
which was then confirmed by immunohistofluorescence
for Vimentin.
Hence, although interstitial fibrosis measurement
using standard method (Sirius Red Staining) did not re-
veal a difference between these groups, mechanistic ana-
lysis showed that this process was slowed down in the
MP group compared to the CS group. These results sug-
gest that uncovering MP benefits may be difficult using
standard methods of evaluation. We previously came to
a similar conclusion during the evaluation of the Lifeport
machine [19], when the use of KPS, of identical compos-
ition than MPS, made comparison between MP and CS
more difficult as there was only slight differences in
survival and typical biochemical evaluation. There also,
proteinuria was one of the most discriminating markers.
In this previous study as well as the present one, the
bias of the perfusion solution was very apparent. In both
studies, multivariate analyses revealed both an individual
effect of the machine and the solution on outcome mar-
kers, but more importantly showed a significant effect of
the combination of factors. Our results herein show that
the evidence for MP benefits is difficult to find when
using IGL1 in CS and MP.We previously reported little differences between IGL1
and MPS in MP when follow up was limited to 30 days,
with a slight advantage for the use of MPS in terms of
histological injury. Herein, longer follow up highlighted
differences between both IGL groups and MPS-CS as evi-
denced by several parameters such as survival and pro-
teinuria, as well as lesional markers detected by RTqPCR.
Both IGL groups displayed reduced expression of TGFβ
and Vimentin, which was confirmed by immunostaining,
suggesting a better level of protection obtained through
the use of the PEG-containing solution.
The use of PEG involves the concept of immunoca-
mouflage [14], we thus investigated the immune response
within the grafts. Interestingly, classical evaluation of
immune cell invasion did not reveal differences between
the groups (data not shown), however RTqPCR evalu-
ation of immune markers determine some effects of
IGL compared to MPS. IGL preserved grafts presented
reduced levels of IL-10 and IL-1Rn, typical of Th2
phenotype. As Th2 immunity is linked to the develop-
ment of fibrosis [27], the protection provided by IGL
appears to be directed against fibrotic pathways.
Further investigation of innate immunity by RTqPCR
analysis revealed that expression of TNFα, TLRs and
Pselectin was the lowest in IGL grafts. TNF-α is one of
the earliest cytokine produced in response to stresses,
particularly by resident dendritic cells [28]. TLRs are
well described effectors of ischemia reperfusion injury
[29] and TLR4 as recently been shown to have a central
role in kidney graft injury, both on the short and long
term [30]. Pselectin is a marker of endothelial activation.
Hence, the use of IGL appears to lower the immunogen-
icity of the graft, confirming our previous findings in an
allotransplantation model [31].
The benefits from combining IGL and MP were more
difficult to determine. Indeed, the only statistical differ-
ence between the IGL-CS and IGL-MP groups was in
the recorded level of TNFα expression, which was sig-
nificantly lower than controls, suggesting a negative
regulation taking place within the kidney at the time of
analysis. More data points would be necessary to de-
scribe in further detail the dynamics of immune regula-
tion in this context. However, the difficulty in assessing
the benefits of the combined use of IGL1 and MPS is
concordant with retrospective and prospective studies
published in the literature which have shown the benefit
of MP [32] but did not clearly demonstrate the inde-
pendent effect of MP with different preservation solu-
tions. However, IGL-MP group results were more
consistently reaching statistically significant difference to
MPS-CS compared to the other groups. Thus, combin-
ing MP and IGL increases the protective potential of
each technique to better preserve the graft against
chronic adverse outcomes.
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classical approached such as histology and biochemistry
underlines the need for tools providing in depth analysis
of the tissue phenotypes. Herein we demonstrate that al-
though two tissues show similar levels of fibrosis, one
group is much further along on the path towards fibrosis
development according to the transcripts expressed by
the cells. These results highlight the need for further re-
search on in depth biomarkers, particularly using highly
reproducible models to identify specific reporters of in-
jury linked to variations in a single parameter.
In conclusion, this study demonstrates that the evalu-
ation of machine perfusion is highly dependant on the
solution used. Multivariate analysis of variance con-
firmed that the perfusion solution was significantly asso-
ciated with the result, and moreover that combination of
solution and machine could have additive effects. IGL-1
used in either machine or static preservation offers simi-
lar levels of protection than standard MP. Importantly,
our data is in contradiction with a previous report from
our team with a shorter follow up time. This highlight
the needs for proper follow up durations in preclinical
studies, particularly in research areas where chronic out-
come is of crucial importance. The compatibility of IGL-
1 with both machine perfusion and static storage could
represent an advantage for clinical teams when choosing
the correct solution to use for multi-organ collection.
The path towards improving machine perfusion, and
organ quality, may thus involve the optimization of the
solution and the correct use of colloids.
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